Plant-Based Investment Corp. (CWWBF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.32: the stock has moved about 68% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerPlant-Based Investment Corp. (CWWBF) trades at $0.00001. Plant-Based Investment Corp. is a principal investment firm focused on the cannabis industry. The company employs fundamental analysis to invest in public cannabis companies. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for CWWBF: CWWBF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CWWBF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CWWBF: 1/2 scored disciplines lean bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Plant-Based Investment Corp. (CWWBF) Healthcare & Pipeline Overview
Plant-Based Investment Corp. is a principal investment firm based in Canada, specializing in investments within the cannabis industry. The firm utilizes fundamental analysis and a combination of bottom-up and top-down stock picking to build its portfolios, focusing primarily on public cannabis companies.
What Is the Investment Thesis for CWWBF?
Plant-Based Investment Corp. presents a unique investment opportunity for those seeking exposure to the cannabis industry through a principal investment firm model. With a profit margin of 177.7% and a gross margin of 100.0%, the company demonstrates strong profitability, although the $0.00B market cap indicates it is still in early stages. The company's investment strategy, centered around fundamental analysis and a combination of bottom-up and top-down stock picking, could drive growth as the cannabis market matures. Key value drivers include strategic investments in promising cannabis companies and effective portfolio management. Catalysts include the potential for regulatory changes in the cannabis industry and the successful expansion of portfolio companies. However, potential risks include the volatility of the cannabis market and the competitive landscape of investment firms.
Based on FMP financials and quantitative analysis
CWWBF Key Highlights
Profit Margin of 177.7% indicates strong operational efficiency in its investment strategies.
- Gross Margin of 100.0% suggests effective cost management in its investment activities.
- Beta of 0.32 indicates lower volatility compared to the overall market, potentially offering a more stable investment profile.
- Principal investment firm model allows for direct involvement in the growth and development of cannabis companies.
- Focus on publicly traded cannabis companies provides liquidity and transparency for investors.
Who Are CWWBF's Competitors?
CWWBF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AVCNF Avicanna Inc. | $0.08 | 0.00% | $10.6M | 529-signal |
| PLNH Planet 13 Holdings Inc. | $0.13 | -7.14% | $42.7M | 429-signal |
| DBCCF Decibel Cannabis Company Inc. | $1.27 | -3.39% | $49.0M | 459-signal |
| ZYBT Zhengye Biotechnology Holding Limited | $1.59 | +1.27% | $75.4M | 465-pillar |
| CWBHF Charlotte's Web Holdings, Inc. | $0.33 | -3.93% | $88.4M | 519-signal |
| AAWH Ascend Wellness Holdings, Inc. | $0.49 | +1.36% | $98.7M | 439-signal |
| BGM BGM Group Ltd. | $0.28 | +0.92% | $105M | 455-pillar |
| MEDXF Medexus Pharmaceuticals Inc. | $3.59 | -1.40% | $114M | 479-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are CWWBF's Key Strengths?
High profit margin of 177.7% indicates efficient operations.
- Gross margin of 100.0% suggests effective cost management.
- Low beta of 0.32 indicates lower volatility compared to the market.
- Focus on the growing cannabis industry provides significant growth potential.
What Are CWWBF's Weaknesses?
Small market capitalization of $0.00B indicates limited scale and resources.
- Dependence on the cannabis industry exposes the firm to regulatory and market risks.
- Limited diversification beyond cannabis investments.
- OTC market listing may limit access to institutional investors.
What Could Drive CWWBF Stock Higher?
Potential regulatory changes in the cannabis industry could create new investment opportunities.
- Successful expansion of portfolio companies into new markets can drive revenue growth.
- Strategic partnerships with established cannabis companies can enhance market access and expertise.
- Development of innovative cannabis technologies can improve cultivation and processing efficiency.
- Increasing acceptance and legalization of cannabis for medical and recreational use.
What Are the Key Risks for CWWBF?
Financial-distress signal — its Altman Z-Score of -8.46 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-96.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory uncertainty and changes in cannabis laws could negatively impact the industry.
- Increasing competition from other investment firms and cannabis companies.
- Market volatility and price fluctuations in cannabis stocks.
- Economic downturns that could impact investment returns.
- Limited liquidity due to OTC market listing may hinder trading activity.
What Are the Growth Opportunities for CWWBF?
- Expansion into New Cannabis Markets: As cannabis legalization continues to spread across North America and globally, Plant-Based Investment Corp. has the opportunity to expand its investment portfolio into new and emerging markets. This includes investing in companies operating in states or countries that have recently legalized cannabis, offering significant growth potential. The global cannabis market is projected to reach $90.4 billion by 2026, providing a substantial market for expansion.
- Strategic Partnerships with Cannabis Companies: Forming strategic partnerships with established and emerging cannabis companies can provide Plant-Based Investment Corp. with access to proprietary technologies, distribution networks, and market expertise. These partnerships can enhance the firm's ability to identify and invest in high-growth opportunities within the cannabis sector. The timeline for establishing these partnerships is ongoing, with potential deals emerging as the market evolves.
- Diversification into Cannabis-Related Products and Services: Plant-Based Investment Corp. can diversify its investment portfolio by expanding into cannabis-related products and services, such as cannabis-infused beverages, edibles, and wellness products. This diversification can reduce the firm's reliance on direct cannabis cultivation and distribution, mitigating regulatory and market risks. The market for cannabis-infused products is expected to grow significantly in the coming years, offering a lucrative opportunity for diversification.
- Investment in Cannabis Technology and Innovation: Investing in companies developing innovative technologies for cannabis cultivation, processing, and distribution can provide Plant-Based Investment Corp. with a competitive edge. This includes technologies such as precision agriculture, automated harvesting, and advanced extraction methods. The cannabis technology market is rapidly evolving, with new innovations emerging regularly, creating opportunities for strategic investments.
- Development of Proprietary Investment Strategies: Plant-Based Investment Corp. can develop proprietary investment strategies tailored to the unique characteristics of the cannabis market. This includes developing sophisticated analytical models for evaluating cannabis companies and identifying undervalued assets. By leveraging its expertise and market knowledge, the firm can generate superior returns for its investors. The timeline for developing these strategies is ongoing, with continuous refinement based on market dynamics.
What Are CWWBF's Competitive Advantages?
- Expertise in the cannabis industry provides a competitive advantage in identifying promising investment opportunities.
- Fundamental analysis approach allows for a deeper understanding of the intrinsic value of cannabis companies.
- Combination of bottom-up and top-down stock picking enhances investment decision-making.
- Established network of contacts within the cannabis industry facilitates access to deal flow and market intelligence.
What Does CWWBF Do?
Plant-Based Investment Corp., headquartered in Toronto, Canada, operates as a principal investment firm with a specific focus on the burgeoning cannabis industry. The company's core strategy involves identifying and investing in publicly traded cannabis companies, leveraging a fundamental analysis approach combined with both bottom-up and top-down stock selection methodologies. This dual approach allows the firm to assess the intrinsic value of individual companies while also considering broader macroeconomic trends and industry dynamics. The firm's investment activities are centered around creating a portfolio of cannabis-related assets, aiming to capitalize on the growth potential within this evolving sector. By focusing on publicly traded companies, Plant-Based Investment Corp. seeks to provide investors with exposure to the cannabis market through a diversified and actively managed investment vehicle. The company's investment decisions are driven by in-depth research and analysis, with a commitment to identifying companies with strong fundamentals and promising growth prospects within the cannabis landscape. Plant-Based Investment Corp. aims to deliver long-term value to its investors by strategically allocating capital to companies that demonstrate strong growth potential and sound financial management within the cannabis sector. The company's investment philosophy is rooted in a disciplined approach to risk management and a commitment to thorough due diligence, ensuring that investment decisions are based on a comprehensive understanding of the market and the individual companies within it.
What Products and Services Does CWWBF Offer?
- Invests in publicly traded cannabis companies.
- Employs fundamental analysis for investment decisions.
- Utilizes a combination of bottom-up and top-down stock picking approaches.
- Creates portfolios of cannabis-related assets.
- Manages and monitors its investments in the cannabis sector.
- Conducts due diligence on potential investment targets.
- Seeks to capitalize on the growth potential within the cannabis industry.
How Does CWWBF Make Money?
- Generates revenue through capital appreciation of its investments in cannabis companies.
- Profits from dividends and other distributions received from its portfolio companies.
- Employs a principal investment strategy, directly investing its own capital.
- Utilizes fundamental analysis to identify undervalued cannabis companies with growth potential.
What Industry Does CWWBF Operate In?
Plant-Based Investment Corp. operates within the Drug Manufacturers - Specialty & Generic industry, a segment of the broader healthcare sector. The cannabis industry is experiencing rapid growth, driven by increasing legalization and acceptance of cannabis for both medical and recreational use. This growth presents opportunities for investment firms like Plant-Based Investment Corp. Competitors include FFNTF (Fire & Flower Holdings Corp.), GPFT (Green Power Motor Company Inc.), GSAC (Global Synergy Acquisition Corp.), HMPQ (Hempacco Co., Inc.), and INSO (Inspirato Incorporated), each with varying focuses within the cannabis or related industries. The market is characterized by evolving regulations and increasing competition, requiring firms to adapt and innovate to maintain a competitive edge.
Who Are CWWBF's Key Customers?
- Investors seeking exposure to the cannabis industry.
- Institutional investors looking for diversified cannabis investment opportunities.
- High-net-worth individuals interested in the cannabis market.
- Funds and endowments seeking to allocate capital to the cannabis sector.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 44 |
| 2026-08-26 | 44 |
| 2026-08-29 | 44 |
| 2026-09-01 | 44 |
| 2026-09-04 | 44 |
| 2026-09-07 | 44 |
| 2026-09-10 | 44 |
What changed?
The score has stayed at 44.
Over the same 18 days the stock moved +0.0%.
Financial Health
Plant-Based Investment Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.46 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Plant-Based Investment Corp. stands at -96.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -46.5%, showing how much profit it generates from its asset base. A current ratio of 2.03 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
Plant-Based Investment Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Paul Jason Crath. CWWBF has traded publicly since 2018.
CWWBF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- High profit margin of 177.7% indicates efficient operations.
- Gross margin of 100.0% suggests effective cost management.
- Low beta of 0.32 indicates lower volatility compared to the market.
- Focus on the growing cannabis industry provides significant growth potential.
Bear Case
- Small market capitalization of $0.00B indicates limited scale and resources.
- Dependence on the cannabis industry exposes the firm to regulatory and market risks.
- Limited diversification beyond cannabis investments.
- OTC market listing may limit access to institutional investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CWWBF Latest News
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · Jun 10, 2025
CWWBF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CWWBF.
Price Targets
Wall Street price target analysis for CWWBF.
CWWBF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CWWBF; grades run from A+ (80-100) to F (below 30).
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Leadership: Paul Jason Crath
CEO
Paul Jason Crath serves as the CEO of Plant-Based Investment Corp. His background includes experience in the financial services sector, with a focus on investment management and corporate finance. He has held various leadership positions in investment firms, where he was responsible for developing and implementing investment strategies. Crath's expertise lies in identifying and evaluating investment opportunities in emerging industries, with a particular emphasis on the cannabis sector. He holds a degree in Finance from a leading business school.
Track Record: Under Paul Jason Crath's leadership, Plant-Based Investment Corp. has focused on strategic investments in the cannabis industry, achieving a high profit margin. He has overseen the development of the firm's fundamental analysis approach and the implementation of its bottom-up and top-down stock picking strategies. Crath has also been instrumental in establishing partnerships with key players in the cannabis market, enhancing the firm's access to deal flow and market intelligence.
CWWBF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Plant-Based Investment Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This can result in increased risks for investors due to the potential for less transparency and liquidity compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Limited liquidity due to low trading volume on the OTC Other tier.
- Potential for wider bid-ask spreads, increasing transaction costs.
- Less stringent regulatory oversight compared to exchange-listed companies.
- Higher risk of price manipulation and fraud.
- Limited access to institutional investors due to OTC listing.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive positioning.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and price volatility.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Established presence in the cannabis industry.
- Experienced management team with expertise in investment management.
- Focus on fundamental analysis and disciplined investment strategies.
- High profit margin indicates efficient operations.
- Gross margin suggests effective cost management.
Plant-Based Investment Corp. Healthcare Stock: Key Questions Answered
Is CWWBF a good stock?
Stock Expert AI does not rate CWWBF buy, sell or hold. Plant-Based Investment Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Plant-Based Investment Corp. do?
Plant-Based Investment Corp. operates as a principal investment firm focused on the cannabis industry. The company invests in publicly traded cannabis companies, employing fundamental analysis and a combination of bottom-up and top-down stock picking approaches. Its goal is to create a portfolio of cannabis-related assets and capitalize on the growth potential within this evolving sector.
What are the key factors to evaluate for CWWBF?
Evaluate CWWBF on fundamentals, analyst consensus, and risk factors. Plant-Based Investment Corp. presents a unique investment opportunity for those seeking exposure to the cannabis industry through a principal investment firm model. Not financial advice.
How frequently does CWWBF data refresh on this page?
CWWBF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CWWBF's recent stock price performance?
Plant-Based Investment Corp. (CWWBF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High profit margin of 177.7% indicates efficient operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CWWBF overvalued or undervalued right now?
Plant-Based Investment Corp. (CWWBF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of CWWBF?
Yes, most major brokerages offer fractional shares of Plant-Based Investment Corp. (CWWBF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CWWBF's earnings and financial reports?
Plant-Based Investment Corp. (CWWBF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for CWWBF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market listing increases investment risk.
- Cannabis industry is subject to regulatory changes and uncertainty.